Celebrating neuropathology's contributions to Alzheimer's Disease Research Centers
- PMID: 41085158
- PMCID: PMC12519528
- DOI: 10.1002/alz.70734
Celebrating neuropathology's contributions to Alzheimer's Disease Research Centers
Abstract
Our understanding of Alzheimer's disease (AD) and related dementias (ADRD) has grown exponentially, thanks to significant investments by the National Institute on Aging (NIA). This article celebrates the 40th anniversary of the NIA's Alzheimer's Disease Research Centers, highlighting the pivotal role of neuropathology as the bedrock for neurodegeneration research. Neuropathology has championed the key principles of proteinopathy, selective vulnerability, and stereotypic spread. Furthermore, neuropathologic studies advanced our understanding of ADRD prevalence, heterogeneity, clinical-pathological correlations, and genetic underpinnings, spurring biomarker development for target engagement and disease monitoring. Disease-modifying therapies for AD were inspired and informed by neuropathology. The neuropathology community is poised to refine diagnostics, leveraging digital pathology and integrating genetics and pathomics to enhance subtyping for novel precision medicine approaches. Despite some common misconceptions and logistical challenges, neuropathology continues to be a critical component of the ADRD research infrastructure, serving as a key bridge between allied basic and clinical sciences. HIGHLIGHTS: We celebrate 40 years of NIA-funded ADRCs and their contributions through neuropathology studies that have significantly advanced our understanding and treatment of ADRD. Neuropathology uncovers principles of neurodegenerative disease: proteinopathy, selective vulnerability, and stereotypic spread, informing diagnostics and therapies. Development of AD biomarkers with reference to neuropathology enhances accuracy in diagnosis and monitoring, paving the way for targeted disease-modifying therapies. Integration of digital pathology, genetics, and novel tools in neurodegeneration research promises advanced precision medicine approaches and refined diagnostics. Misconceptions and logistical challenges to neuropathological research are addressed to improve understanding and collaboration.
Keywords: Alzheimer disease; dementia; neurodegenerative diseases; neuropathology; pathomics.
© 2025 The Author(s). Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.
Conflict of interest statement
D.L.F. has received authorship payment from MedLink, LLC and an honorarium from Topline Bio. K.M. has received consulting fees from Spear Bio. E.B.L. has received consulting fees from Eli Lilly and Wavebreak Therapeutics. Other author disclosures are available in the Supporting Information.
Figures
References
-
- Katzman R. Editorial: the prevalence and malignancy of Alzheimer disease. a major killer. Arch Neurol. 1976;33:217‐218. - PubMed
-
- Brion J‐P, Passareiro H, Nunez J, Flament‐Durand J. Immunological demonstration of tau protein into neurofibrillary tangles of Alzheimer's disease. Arch Biol (Bruxelles). 1985;95:229‐235.
Publication types
MeSH terms
Grants and funding
- UE5NS070680/GF/NIH HHS/United States
- R01AG075802/GF/NIH HHS/United States
- P30AG072976/GF/NIH HHS/United States
- P30AG019610/GF/NIH HHS/United States
- P30AG072980/GF/NIH HHS/United States
- P30AG072977/GF/NIH HHS/United States
- P30AG066515/GF/NIH HHS/United States
- P30AG066514/GF/NIH HHS/United States
- R01AG054008/GF/NIH HHS/United States
- R01NS095252/GF/NIH HHS/United States
- R01AG062348/GF/NIH HHS/United States
- P30AG062677/GF/NIH HHS/United States
- R01AG062517/GF/NIH HHS/United States
- U24NS133949/GF/NIH HHS/United States
- P30AG072972/GF/NIH HHS/United States
- K01AG070326/GF/NIH HHS/United States
- RF1NS128908/GF/NIH HHS/United States
- P30AG066508/GF/NIH HHS/United States
- P30AG072947/GF/NIH HHS/United States
- R24AG073199/GF/NIH HHS/United States
- P30AG066509/GF/NIH HHS/United States
- P30AG062715/GF/NIH HHS/United States
- U19AG066567/GF/NIH HHS/United States
- U19AG060909/GF/NIH HHS/United States
- UM1MH130981/GF/NIH HHS/United States
- UM1MH134812/GF/NIH HHS/United States
- U24AG072458/GF/NIH HHS/United States
- U24NS133945/GF/NIH HHS/United States
- U24NS135651/GF/NIH HHS/United States
- R24AG073137/GF/NIH HHS/United States
- U01NS137500/GF/NIH HHS/United States
- U01NS137484/GF/NIH HHS/United States
- U01AG082350/GF/NIH HHS/United States
- R01AG082730/GF/NIH HHS/United States
- R01AG087226/GF/NIH HHS/United States
- R01AG088656/GF/NIH HHS/United States
- R01AG060942/GF/NIH HHS/United States
- R01AG080585/GF/NIH HHS/United States
- R01NS129609/GF/NIH HHS/United States
- R01AG069912/GF/NIH HHS/United States
- P30AG066468/GF/NIH HHS/United States
- U19AG068054/GF/NIH HHS/United States
- R01MH116046/GF/NIH HHS/United States
- R01AG090551/GF/NIH HHS/United States
- P30AG072959/GF/NIH HHS/United States
- DP2AG086138/GF/NIH HHS/United States
- R01AG082346/GF/NIH HHS/United States
- P30AG066507/GF/NIH HHS/United States
- P01AG003991/GF/NIH HHS/United States
- P30AG066444/GF/NIH HHS/United States
- U19AG024904/GF/NIH HHS/United States
- U19AG032438/GF/NIH HHS/United States
- R01AG068319/GF/NIH HHS/United States
- R01AG053267/GF/NIH HHS/United States
- R01NS111978/GF/NIH HHS/United States
- UF1NS120463/GF/NIH HHS/United States
- P50AG023501/GF/NIH HHS/United States
- P01AG019724/GF/NIH HHS/United States
- U01AG057195/GF/NIH HHS/United States
- U19AG063911/GF/NIH HHS/United States
- P30AG072958/GF/NIH HHS/United States
- P30AG066512/GF/NIH HHS/United States
- R01AG077422/GF/NIH HHS/United States
- U01OH012486/GF/NIH HHS/United States
- U24NS135568/GF/NIH HHS/United States
- R01AG087280/GF/NIH HHS/United States
- R13AG059336/GF/NIH HHS/United States
- P30AG072979/GF/NIH HHS/United States
- P01AG066597/GF/NIH HHS/United States
- P01AG084497/GF/NIH HHS/United States
- RF1AG065341/GF/NIH HHS/United States
- P30AG062429/GF/NIH HHS/United States
- P30AG062421/GF/NIH HHS/United States
- P30AG066530/GF/NIH HHS/United States
- P30AG066518/GF/NIH HHS/United States
- P30AG066462/GF/NIH HHS/United States
- P30AG072975/GF/NIH HHS/United States
- P30AG072978/GF/NIH HHS/United States
- P30AG066519/GF/NIH HHS/United States
- P30AG079280/GF/NIH HHS/United States
- P30AG062422/GF/NIH HHS/United States
- P30AG066511/GF/NIH HHS/United States
- P30AG072946/GF/NIH HHS/United States
- P30AG072973/GF/NIH HHS/United States
- P30AG066506/GF/NIH HHS/United States
- P30AG072931/GF/NIH HHS/United States
- P30AG066546/GF/NIH HHS/United States
- P30AG086401/GF/NIH HHS/United States
- P30AG086404/GF/NIH HHS/United States
- P20AG068082/GF/NIH HHS/United States
- ALZ/Alzheimer's Association/United States
- The Fred and Barbara Erb Family Foundation
- Rainwater Charitable Trust/Tau Consortium
- Karen Strauss Cook Research Scholar Award
- Rainwater Charitable Trust
- SG-25-1416824/Alzheimer's Association Florida Gulf Coast
- 2024-351073/Chan Zuckerberg Initiative
- Silicon Valley Community Foundation
- 685-2023-06/CurePSP
- Allen Institute for Brain Science
- Nancy and Buster Alvord Endowment
- Shanahan Family Foundation
- Barrist Family Foundation
- W81XWH-21-S-TBIPH2/U.S. Department of Defense
- Stuart Katz and Dr. Jane Martin
- 10,000 Brains NeuroAI Inc
- DeCrane Family Fund for PPA Research
- Bluefield Project to Cure FTD
LinkOut - more resources
Full Text Sources
Medical
